Gynesonics, Inc.

Gynesonics designs and develops new and advanced technologies for improving women’s health. The company is focused on providing to women, and the physicians who care for them, an incision-free, uterus-preserving option to treat symptomatic uterine fibroids. The Sonata™ system combines intrauterine sonography with radio-frequency ablation to precisely locate and ablate uterine fibroids associated with heavy menstrual symptoms in a simple, same-day procedure. The system is cleared for sale in Europe (CE Mark) and the company is currently enrolling its US pivotal trial to evaluate safety and effectiveness. Sonata offers the potential to reduce the number of more invasive procedures, including hysterectomy, and to offer women greater choices in the treatment of this very common condition.


Recent News

July 22, 2015
GYNESONICS RAISES $43 MILLION IN EQUITY FINANCING - Endeavour Vision and Abingworth Lead Funding

 


Company Info
 
Country: USA
Industry:    Medtech
Sector: medical technology
Status: Unrealized
Vehicle: Endeavour Medtech Growth LP


Key persons
 Christopher M. Owens President & CEO


Company website
 www.gynesonics.com/


Endeavour Vision Team
 
Robert OHolla
Alexander Schmitz
© Endeavour Vision SA 2006-2017 Terms & Conditions